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Abstract
Current geographic spread of documented severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infections shows heterogeneity. This study explores the role of age in
potentially driving differentials in infection spread, epidemic potential, and rates of disease
severity and mortality across countries. An age-stratified deterministic mathematical model
that describes SARS-CoV-2 transmission dynamics was applied to 159 countries and terri-
tories with a population�1 million. Assuming worst-case scenario for the pandemic, the
results indicate that there could be stark regional differences in epidemic trajectories driven
by differences in the distribution of the population by age. In the African Region (median
age: 18.9 years), the median R0 was 1.05 versus 2.05 in the European Region (median age:
41.7 years), and the median (per 100 persons) for the final cumulative infection incidence
was 22.5 (versus 69.0), for severe and/or critical disease cases rate was 3.3 (versus 13.0),
and for death rate was 0.5 (versus 3.9). Age could be a driver of variable SARS-CoV-2 epi-
demic trajectories worldwide. Countries with sizable adult and/or elderly populations and
smaller children populations may experience large and rapid epidemics in absence of inter-
ventions. Meanwhile, countries with predominantly younger age cohorts may experience
smaller and slower epidemics. These predictions, however, should not lead to complacency,
as the pandemic could still have a heavy toll nearly everywhere.
Introduction
The current geographic spread of the documented severe acute respiratory syndrome corona-
virus 2 (SARS-CoV-2) [1] infections and associated Coronavirus Disease 2019 (COVID-2019)
[1] shows heterogeneity [2]. This remains unexplained but may possibly reflect delays in virus
introduction into the population, differentials in testing and/or reporting, differentials in the
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As our understanding of the SARS-CoV-2 transmission dynamics is rapidly evolving [3],
the role of age in the epidemiology of this infection is becoming increasingly apparent [4–7].
In a recent study examining SARS-CoV-2 epidemiology in China [4], we quantified the effect
of age on the biological susceptibility to infection acquisition. We found that relative to individ-
uals aged 60–69 years, susceptibility was 0.06 in those aged 0–19 years, 0.34 in those aged 20–
29 years, 0.57 in those aged 30–39 years, 0.69 in those aged 40–49 years, 0.79 in those aged 50–
59 years, 0.94 in those aged 70–79 years, and 0.88 in those aged�80 years (S1 Fig in S1 File).
Notably, this age-dependence was estimated after accounting for the assortativeness in popula-
tion mixing by age [4].
Age also affects disease progression [7–10] and mortality risk [11–13] among those infected.
The proportion of infections that eventually progress to severe disease, critical disease, or
death, increases rapidly with age, especially among those�50 years of age (S2 Fig in S1 File)
[8–12]. Since the demographic structure of the population (that is the distribution of the popu-
lation across the different age groups) varies by country and region, this poses a question as to
the extent to which age effects can drive geographic differentials in the basic reproduction
number (R0), epidemic potential, and rates of disease severity and mortality. R0 is defined here
as the number of infections caused by an index case in a fully susceptible population [14].
We aimed here to provide an answer to this question and to estimate for each country (with
a population�1 million), region, and globally, R0, and the rate per 100 persons (out of the
total population by the end of the epidemic cycle) of each of the cumulative number of inci-
dent infections, mild infections, severe and/or critical disease cases, and deaths, in addition to
the number of days needed for the national epidemic to reach its incidence peak (a measure of
how fast the epidemic will grow).
Materials and methods
We adapted and applied our recently developed deterministic mathematical model [4] describ-
ing SARS-CoV-2 transmission dynamics in China (S3 Fig in S1 File), to 159 countries and ter-
ritories, virtually covering the world population [15]. Since our focus was on investigating the
natural course of the SARS-CoV-2 epidemic and on assessing its full epidemic potential, the
model was applied assuming the worst-case scenario for the epidemic in each country, that is
in absence of any intervention.
The model stratified the population into compartments according to age (0–9, 10–19, . . .,
�80 years), infection status (uninfected, infected), infection stage (mild, severe, critical), and
disease stage (severe, critical), using a system of coupled nonlinear differential equations (Sec-
tion 1 in S1 File). Susceptible individuals in each age group were assumed at risk of acquiring
the infection at a hazard rate that varies based on the age-specific susceptibility to the infection
(S1 Fig in S1 File), the infectious contact rate per day, and the transmission mixing matrix
between the different age groups (Section 1 in S1 File). Following a latency period of 3.69 days
[16–19], infected individuals develop mild, severe, or critical infection, as informed by the
observed age-specific distribution of cases across these infection stages in China [8–10]. The
duration of infectiousness was assumed to last for 3.48 days [8, 16, 18, 19] after which individu-
als with mild infection recover, while those with severe and critical infection develop, respec-
tively, severe and critical disease over a period of 28 days [8] prior to recovery. Individuals
with critical disease have the additional risk of disease mortality, as informed by the age-strati-
fied disease mortality rate in China [11, 12].
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Model parameters were based on current data for SARS-CoV-2 natural history and epide-
miology, or through model fitting to the China outbreak data [4] (S1, S2 Tables in S1 File).
Namely, the overall infectious contact rate, age-specific biological susceptibility profile, and
age-specific mortality rate (assuming the observed case fatality rate) were assumed as those in
China [4]. The population size, demographic structure, and life expectancy in countries and
territories with a population of�1 million, as of 2020, were extracted from the United Nations
World Population Prospects database [15]. Whenever available data for a parameter covered a
wider age bracket, we assumed that this parameter has the same value for all age groups within
that bracket. Model parameters, definitions, values, and justifications are in Section B and S1,
S2 Tables in S1 File.
Ranges of uncertainty around model-predicted outcomes were determined using five-hun-
dred simulation runs that applied Latin Hypercube sampling [20, 21] from a multidimensional
distribution of the model parameters, including both the natural history parameters and the
age-specific susceptibility profile. At each run, input parameter values were selected from
ranges specified by assuming ±30% uncertainty around parameters’ point estimates [22–26].
The resulting distribution for each model-predicted outcome was then used to derive the most
probable estimate (based on maximum likelihood) and 95% uncertainty interval. Mathemati-
cal modelling analyses were performed in MATLAB R2019a [27], while statistical analyses
were performed in STATA/SE 16.1 [28].
Results
In what follows, we highlight results for select (mostly populous) countries that are of broad
geographic representation and characterized by diverse demographic structures. These include
Brazil, China, Egypt, India, Indonesia, Italy, Niger, Pakistan, and USA. Estimates and uncer-
tainty ranges for these countries are illustrated in Figs 1, 3 and 4. Detailed results for all 159
countries and territories are in S3-S8 Tables in S1 File.
Fig 1A shows the estimated R0 in these select countries, which was highest in Italy at 2.30,
followed by USA and China at 1.95, Brazil at 1.75, Indonesia at 1.55, India at 1.45, Egypt at
1.35, Pakistan at 1.25, and lowest in Niger at 0.93. Country-specific estimates of R0 grouped by
World Health Organization (WHO) region are illustrated in Fig 2. The median R0 was 1.05
(range: 0.93–1.95) in African Region (AFRO), 1.45 (range: 0.98–1.75) in Eastern Mediterra-
nean Region (EMRO), 1.55 (range: 1.15–1.95) in South-East Asia Region (SEARO), 1.65
(range: 1.25–2.28) in Region of the Americas (AMRO), 1.85 (range: 1.25–2.30) in Western
pacific Region (WPRO), and 2.05 (range: 1.25–2.30) in European Region (EURO). Globally,
the median R0 was 1.55 with a range of 0.93–2.30.
Fig 1B shows the estimated number of days needed for the national epidemic to reach its
incidence peak in the select countries. In Italy, the peak was reached after 122 days (~4
months), whereas in Pakistan it was reached after 350 days (nearly a year). Meanwhile, since
R0<1, no epidemic would emerge in Niger. Of note that the number of days needed for the
national epidemic to reach its incidence peak depends on the population size in addition to
R0—it takes more time for the epidemic to reach its peak in larger nations (S3-S8 Tables in S1
File).
The estimated incidence rate per 100 persons in the nine select countries, defined as the
cumulative number of infections by the end of the epidemic cycle out of the total population,
was highest in Italy at 75.5 and lowest in Pakistan at 33.0 (Fig 3A). Across world regions, the
median incidence rate per 100 persons was 22.5 (range: 0.25–63.5) in AFRO, 45.0 (range: 1.5–
65.0) in EMRO, 49.0 (range: 25.0–66.5) in SEARO, 53.0 in AMRO (range: 35.0–70.5), 63.5
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(range: 31.0–76.5) in WPRO, and 69.0 (range: 31.0–75.5) in EURO, and 49.0 (range: 0.25–
76.5) globally.
The estimated death rate per 100 persons in the nine select countries followed the same pat-
tern, where it was highest in Italy at 4.7 and lowest in Pakistan at 0.9 (Fig 3B). Across world
regions, the median death rate per 100 persons was 0.5 (range: 0.0–2.8) in AFRO, 0.9 (range:
0.0–2.0) in EMRO, 1.6 (range: 0.8–2.9) in SEARO, 2.0 in AMRO (range: 1.0–4.2), 2.7 (range:
0.8–5.3) in WPRO, and 3.9 (range: 0.8–4.7) in EURO, and 1.6 (range: 0.0–5.3) globally.
The estimated rate of mild infections per 100 persons in the nine select countries was high-
est in Italy at 60.5 and lowest in Pakistan at 27.0 (Fig 4A). Across world regions, the median
per 100 persons was 17.0 (range: 0.25–52.5) in AFRO, 39.0 (range: 1.5–55.0) in EMRO, 41.0
(range: 23.0–54.5) in SEARO, 43.5 in AMRO (range: 29.0–56.5), 51.5 (range: 27.0–61.5) in
WPRO, and 56.5 (range: 25.0–65.0) in EURO, and 41.0 (range: 0.25–61.5) globally.
Meanwhile, the estimated rate of severe and/or critical disease cases per 100 persons in the
nine select countries was highest in Italy at 14.7 and lowest in Pakistan at 5.0 (Fig 4B). Across
world regions, the median per 100 persons was 3.3 (range: 0.0–11.3) in AFRO, 7.1 (range: 0.3–
Fig 1. Estimates for the basic reproduction number, R0, and the number of days needed for the national epidemic to reach its
incidence peak, in select countries.
https://doi.org/10.1371/journal.pone.0237959.g001
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9.5) in EMRO, 7.7 (range: 4.1–11.9) in SEARO, 8.7 in AMRO (range: 5.0–13.5), 11.5 (range:
5.0–15.5) in WPRO, and 13.0 (range: 4.7–14.7) in EURO, and 8.0 (range: 0.0–15.5) globally.
Discussion
The above results suggest that although this pandemic is a formidable challenge globally, its
intensity and toll in terms of morbidity and mortality may vary substantially by country and
regionally. While some countries, particularly in resource-rich countries, may experience large
and rapid epidemics, other countries, particularly in resource-poor countries, may experience
smaller and slower epidemics. While the scale of the epidemic may be smallest in sub-Saharan
Africa with its young population, it could be intense in countries with a relatively small pro-
portion of children and sizable proportions of adults and/or elderly.
The key finding of this study is the potential role of age in driving divergent SARS-CoV-2
epidemic trajectories and disease burdens. The effect of age reflects the interplay of three main
factors: the variation in susceptibility by age (S1 Fig in S1 File), variation in disease severity
and mortality by age (S2 Fig in S1 File), and variation in demographic structure across coun-
tries (S3-S8 Tables in S1 File). The combined effect of these factors can result in stark varia-
tions in R0 (Fig 2), and consequently epidemic potential, disease severity, and disease mortality
—there was strong correlation between R0 and median age across countries (S4 Fig in S1 File).
Incidentally, the globally diagnosed cases as of July 16, 2020 show a significant correlation with
median age across countries (Spearman correlation coefficient: 0.34 (95% CI: 0.19–0.47),
p<0.001). Although this may be explained by more diagnosed infections being reported by
countries with advanced testing infrastructure, this may support the role of age presented here.
Importantly, as infection transmission dynamics is a non-linear phenomenon, even small
changes in R0, when R0 is in the range of 1–2, can drive considerable differences in epidemic
size and trajectory. Variability by age, though of different magnitude, was also noted in a
recent other research work [7].
Fig 2. Estimates for the basic reproduction number R0 in 159 countries and territories with a population of at
least one million, across World Health Organization regions. These are the African Region (AFRO), Eastern
Mediterranean Region (EMRO), South-East Asia Region (SEARO), Region of the Americas (AMRO), Western Pacific
Region (WPRO), and European Region (EURO). The figure shows also the median age in years and the median R0 for
each world region.
https://doi.org/10.1371/journal.pone.0237959.g002
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An illustration of the role of age can be seen in Niger, a nation with a median age of only 15
years, where the exclusion of children from the population, while maintaining the same sus-
ceptibility profile for the other age groups, would have increased R0 from 0.93 to 2.6. This dem-
onstrates how the lower susceptibility among younger persons, particularly children, acts as a
“herd immunity” impeding the ferocious strength of the force of infection of an otherwise very
infectious virus. This epidemiological feature contrasts that of other respiratory infections,
such as the 2009 influenza A (H1N1) pandemic (H1N1pdm) infection (S5 Fig in S1 File) [29],
where the cumulative incidence was found to be highest among children and young adults,
and much smaller among older adults.
One possible inference to be drawn from the above results is that epidemic size and associ-
ated disease burden could be highest in settings with sizable mid-age and/or elderly popula-
tions, as currently exemplified by Italy. This may also possibly explain sub-national patterns,
such as the large number of diagnosed cases in the city of New York, although additional fine-
grained analyses are needed to delineate within-country heterogeneities in transmission
dynamics.
Fig 3. Estimates for the total number of infections and the total number of deaths per 100 persons in select countries.
https://doi.org/10.1371/journal.pone.0237959.g003
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Another possible inference of relevance to containment efforts relates to the likelihood of
the infection establishing itself in a population. In addition to the role of travel patterns/restric-
tions and multiple introductions for seeding the infection [30], the probability of a major out-
break upon introduction of one infection is given approximately by 1−1/R0 [31, 32].
Accordingly, in countries where R0 is just above the epidemic threshold of R0 = 1, the virus
will need to be introduced multiple times before it can generate sustainable chains of transmis-
sion. In such countries, less disruptive social distancing measures may be sufficient to contain
the epidemic compared to countries with larger R0.
Our study explores the potential effect of age on the epidemiology of SARS-CoV-2, but
other factors that remain poorly understood, may also contribute to driving different epidemic
trajectories. Transmission of the virus may be affected by seasonality, environmental and
genetic factors, differences in social network structure and cultural norms (such as shaking
hands, kissing, and other person-to-person contacts), age-dependent transmissibility effects,
and underlying co-morbidities which also impact disease severity and mortality [33–36].
These factors may have contributed to a slowly growing epidemic in Japan, despite its demo-
graphic structure, as opposed to fast growing epidemics in the European Region and the USA.
This study has limitations. Model estimations are contingent on the validity and generaliz-
ability of input data. Our estimates were based on SARS-CoV-2 natural history and disease
Fig 4. Estimates for the total number of mild infections and the total number of severe and/or critical diseases cases per 100
persons in select countries.
https://doi.org/10.1371/journal.pone.0237959.g004
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progression data from China, but these may not be applicable to other countries. The key fac-
tor driving the heterogeneity in transmission dynamics is the age-specific biological suscepti-
bility profile. We used the susceptibility profile as derived from the China outbreak data [4],
but this may not be generalizable to other countries. More estimates from other countries are
needed to investigate the potential variation in this profile across countries, and different ana-
lytical approaches may also arrive at different estimates [7]. Some of the effects of biological
susceptibility may simply reflect differences in social behavior or the probability of infection
ascertainment. The presence and contribution of such factors are, however, difficult to
disentangle.
Model 10-year age-bands were informed by available empirical evidence, which hindered
analysis using narrower age intervals [37]. While current data on the attack rate from different
countries supports age heterogeneity and lower exposure among children, different countries
show still variation in the age-stratified attack rate (S6, S7 Figs in S1 File). Of note that the
observed lower susceptibility to the infection at younger age [4] does not necessarily imply
absence of infection, but may reflect rapid infection clearance or subclinical infection. This
may impact our estimates depending on these infections’ degree of infectiousness. Two sensi-
tivity analyses assuming a 50% increase in the susceptibility of younger age cohorts or equal
susceptibility among those aged<20 to those aged 20–29 (to somewhat reflect the effect of
subclinical infections) resulted in smaller differences in R0 across countries, but still supported
our findings of wide heterogeneity in R0 (S8 and S9 Figs in S1 File, respectively). It is conceiv-
able that such subclinical infections may have lower viral load, and therefore rapid infection
clearance and limited transmission potential. Data on infection clusters from China and other
countries suggested that children do not appear to play a significant role in the transmission of
this infection [7, 8, 38].
Increasingly, evidence suggests that R0 is higher than assumed here based on fitting the
China epidemic [4, 39, 40], which would increase the R0 values reported here, but will not
affect the relative differences across countries. We assumed a constant overall contact rate
across countries, but contact rate patterns, and therefore R0, can vary across and within coun-
tries [34, 35], and also over time with the implementation of interventions and associated
behavioral changes [41]. There could be also transient effects affecting transmission patterns
and epidemic dynamics [41, 42]. We assumed low degree of assortativeness in age group mix-
ing based on fitting the China epidemic [4], however, a sensitivity analysis assuming high
assortativeness, though yielded higher estimates for R0, still preserved the relative differences
in these estimates across countries (S10 Fig in S1 File).
Our study may have overestimated disease mortality by basing mortality rates on estimates
of the crude case fatality rate in China, as suggested by a recent study [13]. Our results are
based on the most probable value for R0 as estimated through 500 runs of uncertainty analysis.
The latter may have biased our reported results towards lower R0. For instance, the most prob-
able value for R0 in China was 1.95, but the point estimate assuming the baseline values of the
input parameters was higher at 2.10 [4]. Despite these limitations, our parsimonious model,
tailored to the nature of available data, was able to reproduce the epidemic as observed in
China [4], and generated results that are valid to a wide range of model assumptions.
Age appears to be a driver of variable SARS-CoV-2 epidemic trajectories worldwide. Coun-
tries with sizable adult and/or elderly populations and smaller children populations may expe-
rience large and rapid epidemics in absence of interventions, necessitating disruptive social
distancing measures to contain the epidemic. Meanwhile, countries with predominantly youn-
ger age cohorts may experience smaller and slower epidemics and may require less disruptive
social distancing measures to contain the epidemic. These predictions, however, should not
lead to complacency, and should not affect national response in strengthening preparedness
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plans and in implementing prevention interventions, as although many countries are pre-
dicted to have lower R0, these also often coincide with those having limited healthcare capacity
and testing. Once established, and even if smaller in scale due to their predominantly younger
population, the SARS-CoV-2 epidemic would still cause a heavy toll on developing countries
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